We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 4.675 | 4.36 | 4.99 | - | 60,335 | 08:00:27 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.53 | 9.41M |
| Date | Subject | Author | Discuss |
|---|---|---|---|
| 01/10/2020 12:08 | Nobby...I am getting the message insufficient funds but 3 applications pending. Perhaps I have to wait for it to update? | marvelman | |
| 01/10/2020 12:05 | Something very big going down...just flashed up 143p prob to take stops out. As I said yesterday, I would think very big news landing by Monday morning. | oranolio | |
| 01/10/2020 12:00 | Me too please | actybod | |
| 01/10/2020 11:56 | >> marvelman I have given you the coins so now you have to click on the Guild thread entitled SNG001: a potential new treatment for Covid 19. Apply to join the Guild and I will admit you. | nobbygnome | |
| 01/10/2020 11:54 | 175 actually. | d1nga | |
| 01/10/2020 11:52 | Selling unlicensed the drug in France ??? Others to follow :India...Brazil ? ..... | jjmills56 | |
| 01/10/2020 11:50 | nobby...I would appreciate some coins in order to join the Guild thread...not joined one before and not too sure of procedure | marvelman | |
| 01/10/2020 11:28 | Sometimes you are undecided whether to sell or buy more and the slip just prompts you in that direction ha ha. | guss |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
